Category: Press

Investors can still find good dividend stocks in a rising rate environment Hosted by Bill Griffeth and Kelly Evans For more information go to www.cnbc.com. Article by Christine Wang. Stocks mentioned: AMGN The information contained in this tv appearance represents SCM’s opinions, and should not

Starbucks CEO steps down to focus on high-end coffee, shares fall By Lisa Baertlein and Gayathree Ganesan   For more information go to www.reuters.com. Stocks mentioned: SBUX The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized

Wells board changes fail to kill off bogus accounts scandal By Alistair Gray and Kara Scannell For more information go to www.ft.com. The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past

Pay for big bank chief executives jumps nearly 8% By Laura Noonan and Ben McLannahan For more information go to www.ft.com. The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past performance

This is what will create the next housing boom By Akin Oyedele For more information go to www.businessinsider.com. The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee

Why millennials may have more sway on rates than the Fed By Kalyeena Makortoff For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee

Health care stocks are hated, but we’re buying them: Smead CEO By Tom DiChristopher Stocks Mentioned: MRK, PFE, AMGN For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

A-rated Smead: six reasons the US economy is the new ‘big long’ Modern Investor by Chris Sloley For more information go to www.moderninvestor.com. Stocks mentioned: JPM, WFC The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or

Central bank medicine becoming ‘poison’: Expert By Jacob Pramuk For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities

Pfizer 2016 forecast disappoints By Brendan McDermid   For more information go to www.reuters.com. Stocks mentioned: PFE, AGN The information contained in this article represents Smead Capital Management’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee